Home/FibroBiologics/Jason D. Davis
JD

Jason D. Davis

Chief Financial Officer

FibroBiologics

FibroBiologics Pipeline

DrugIndicationPhase
CybroCell™Degenerative Disc Disease (DDD)Phase I / II
CYMS101Multiple Sclerosis (MS)Preclinical
CYWC628Wound HealingDiscovery
CYPS317PsoriasisDiscovery
CYTER915Cancer ImmunotherapyDiscovery
TBC190Thymic InvolutionDiscovery